Literature DB >> 7062132

Spontaneous carotid-cavernous fistula in osteogenesis imperfecta.

J M de Campos, M O Ferro, J A Burzaco, J R Boixadós.   

Abstract

A case of spontaneous carotid-cavernous fistula is presented in a patient suffering from osteogenesis imperfecta tarda type I. The patient was operated on under local anesthesia by intraluminal occlusion of the cavernous carotid artery with a Fogarty catheter, in accordance with Prolo's technique, with total remission except for homolateral loss of vision due to postglaucoma atrophy. the pathogenetic phenomena described in the literature are reviewed, with the suggestion that osteogenesis imperfecta be included with Ehlers-Danlos disease, Marfan's syndrome, and pseudoxanthoma elasticum, as a connective tissue disease with increased weakness of vessel walls that can produce a spontaneous carotid-cavernous fistula. Reports of cases operated on by intraluminal occlusion with various types of balloon-tipped catheters are also reviewed. The good results obtained place this technique among the elective ones for the treatment of carotid-cavernous fistula.

Entities:  

Mesh:

Year:  1982        PMID: 7062132     DOI: 10.3171/jns.1982.56.4.0590

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

1.  Is the retrograde access for endovascular treatment of a traumatic carotid cavernous fistula associated with dissection of the ipsilateral carotid possible?

Authors:  Igor Pagiola; Bruno Amaral; Celso Saito; Darcio Nalli; Henrique Carrete Junior; Michel Frudit
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2021-03-17

2.  CT-findings of carotid-cavernous fistula. A case report.

Authors:  A Leppien; R Eppen; O Pohlenz
Journal:  Neurosurg Rev       Date:  1988       Impact factor: 3.042

3.  Report of two cases of spontaneous direct carotid-cavernous fistula. Diagnostic and therapeutic considerations.

Authors:  G B Bradac; A Bender; G Curio; G Debrun
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.